Latest News & Features
Americas
The Patent Trial and Appeal Board has upheld a patent covering Pozen’s Vimovo in a case against Kyle Bass’s organisation, the Coalition for Affordable Drugs. 24 February 2017
Biotechnology
According to the European Commission, if a biotech company crosses two plants to create a new plant through natural means, the outcome will not be patentable, explains Jane Wainwright of Potter Clarkson in a video interview with LSIPR. 23 February 2017
Americas
The US Supreme Court has declined to review an appeal by Boston Scientific, which had been ordered to pay Maryland-based Mirowski Family Ventures $309 million in a patent dispute covering a defibrillator. 23 February 2017
Americas
The US Supreme Court has “left more questions than it answered” in the Life Technologies v Promega ruling, which was handed down yesterday, according to lawyers. 23 February 2017
Biotechnology
European Council members exchanged views on IP at the Competitiveness Council this week, agreeing that IP is one of the drivers of productivity and economic growth for companies. 22 February 2017
Americas
The US Supreme Court today ruled that supplying a single component of a multi-component invention for manufacture abroad does not constitute patent infringement. 22 February 2017
Americas
The Biosimilars Council, a division of the Association for Accessible Medicines (AAM), has filed a brief in support of Sandoz’s petition for certiorari in the pending Sandoz v Amgen case. 22 February 2017
Asia
Danish biotechnology company Novozymes has won a patent dispute against China-based enzyme makers Shandong Longda Bio-Products and Jiangsu Boli Bioproducts at the Supreme People’s Court of China. 21 February 2017
Americas
The US Department of Justice has asked for an injunction to stop a Louisiana-based drug and dietary supplement manufacturer from distributing misbranded and unapproved new drugs and dietary supplements. 21 February 2017
Americas
A scientist in Kansas has been convicted for conspiring to steal samples of genetically engineered rice seeds from a US biopharmaceutical research facility, Ventria Bioscience. 20 February 2017